GFC Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	49,426	74,597	63,836	-	-	-
Market Cap Growth	-15.84%	16.86%	-	-	-	-
Enterprise Value	49,181	72,097	70,233	-	-	-
Last Close Price	9390.00	14200.00	14500.00	-	-	-
PE Ratio	81.65	134.31	-	-	-	-
PS Ratio	2.79	4.21	3.80	-	-	-
PB Ratio	2.08	3.14	5.86	-	-	-
P/TBV Ratio	2.25	3.39	6.12	-	-	-
P/OCF Ratio	36.16	54.57	21.52	-	-	-
EV/Sales Ratio	2.78	4.07	4.18	-	-	-
EV/EBITDA Ratio	23.40	34.30	21.36	-	-	-
EV/EBIT Ratio	127.32	186.65	41.20	-	-	-
Debt / Equity Ratio	0.32	0.32	0.64	0.90	1.51	0.85
Debt / EBITDA Ratio	3.58	3.58	2.14	3.25	13.64	233.28
Debt / FCF Ratio	-	-	-	20.79	-	-
Net Debt / Equity Ratio	-0.01	-0.01	0.50	0.76	1.41	0.70
Net Debt / EBITDA Ratio	-0.12	-0.12	1.67	2.72	12.80	191.73
Net Debt / FCF Ratio	0.04	0.04	-153.05	17.41	-5.00	-1.73
Asset Turnover	0.66	0.66	-	0.71	0.65	0.60
Inventory Turnover	16.83	16.83	-	11.18	12.84	11.69
Quick Ratio	4.92	4.92	0.48	0.42	0.24	1.46
Current Ratio	5.60	5.60	0.57	0.53	0.34	1.72
Return on Equity (ROE)	3.20%	3.20%	-	21.78%	-28.76%	4.26%
Return on Assets (ROA)	0.90%	0.90%	-	4.42%	-0.02%	-2.37%
Return on Invested Capital (ROIC)	1.75%	1.93%	11.06%	8.82%	-0.04%	-4.28%
Return on Capital Employed (ROCE)	1.20%	1.20%	12.90%	12.50%	-0.10%	-4.30%
Earnings Yield	1.12%	0.74%	-9.32%	-	-	-
FCF Yield	-12.84%	-8.51%	-0.06%	-	-	-
Buyback Yield / Dilution	-52.03%	-52.03%	-206.48%	-0.01%	-0.02%	-100.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.